Production of Bausch&Lomb solutions is moving to Serbia - Takeover of "diclofenac duo" drug is planned

(Photo: bausch.com)

The most famous world producer of eye lenses solutions, Bausch&Lomb will relocate entire production for European market to Serbia, in the PharmaSwiss company. It was announced during the ceremony of celebrating 15 years of successful work of PharmaSwiss in Serbia which more than 500 guests attended.

GM at PharmaSwiss, Dejan Antonic, reminded that the company and Bausch&Lomb are both members of Canadian corporation Valeant.

PharmaSwiss is also planning to take over in early September production of "diclofenac duo" medicine which has currently been produced in Germany. This pharmaceutical form of diclofenac at the Serbian market has existed for more than a decade and it has been in the final stage of obtaining a production permit for almost all the European countries.

The entire production of Bausch&Lomb solutions together with the "diclofenac duo" project will bring additional 3, 5 million packages of different drugs which are annually produced at PharmaSwiss production department in Belgrade. Currently, 10 million packages are produced and a large part will be exported to EU market, it was announced.